|
Age (years)
|
5.5 (1.0–8.3)
|
7.0 (4.0–10.2)
|
1.75 (0.78–1.2)
|
0.015
|
|
Sex female (%)
|
30 (50%)
|
11 (44%)
|
19 (54.3)
|
0.601
|
|
PRISM III at admission
|
20 (13.5–28.7)
|
15 (10–18.5)
|
23 (20–30.5)
|
< 0.0001
|
|
PELOD at admission
|
32 (12–42)
|
12 (10.7–31.2)
|
33 (31–42)
|
< 0.0001
|
|
Community acquired infection
|
56 (93.3%)
|
25 (100%)
|
31 (88.6%)
|
0.133
|
|
Healthcare-associated infection
|
4 (6.7%)
|
0
|
4 (11.4%)
|
|
Systemic infection
|
26 (43.3%)
|
16 (64%)
|
10 (28.5%)
|
0.008
|
|
Pneumonia
|
14 (23.3%)
|
5 (20%)
|
9 (25.7%)
|
0.761
|
|
Use of mechanical ventilation
|
47 (78.3%)
|
15 (60%)
|
32 (91.4%)
|
0.005
|
|
Use of epinephrine as first line
|
29 (48.3%)
|
15 (60%)
|
14 (40%)
|
0.190
|
|
Use of dopamine as first line
|
31 (51.7%)
|
10 (40%)
|
21 (60%)
|
|
Use of dobutamine or milrinone
|
39 (65%)
|
11 (44%)
|
27 (77.1%)
|
0.014
|
|
Use of hydrocortisone
|
44 (73.3)
|
14 (56%)
|
30 (85.7%)
|
0.017
|
|
Use of RBCs transfusion
|
30 (50%)
|
18 (72%)
|
14 (40%)
|
0.019
|
|
Use of RRT
|
24 (40%)
|
2 (8%)
|
22 (62.9%)
|
< 0.0001
|
|
Severe ARDS
|
17 (28.3%)
|
3 (12%)
|
14 (40%)
|
0.022
|
|
Cardiac arrest
|
4 (6.7%)
|
0
|
4 (11.4%)
|
0.133
|
|
Maximal blood lactate (mmol/L)
|
4.3 (2.6, 6.8)
|
2.8 (2.4–3.8)
|
5.5 (3.8–8.9)
|
< 0.0001
|
|
Lactate increase
|
34 (56.7%)
|
7 (28%)
|
27 (79.4%)
|
< 0.0001
|
|
ScvO2 < 70%
|
52 (86.7%)
|
20 (80%)
|
32 (91.4%)
|
0.259
|
|
Myocardial dysfunction on cardiac ultrasound
|
35 (58.3%)
|
0
|
35 (100%)
|
< 0.0001
|
|
Delay from septic shock onset to death
|
3 (1.0–6.7)
|
1.5 (1.0–2.0)
|
3.0 (1.0–7.0)
|
0.327
|
|
Bedside septic shock score (bSSS)
|
4.0 (0–4.0)
|
0 (0–1)
|
4 (4–5)
|
< 0.0001
|
|
Computed septic shock score (cSSS)
|
20.4 (2.3–21.5)
|
2.4 (2.3–2.4)
|
21.4 (20.7–22.3)
|
< 0.0001
|
|
Number of days in PICU
|
5 (2.7–7.0)
|
5 (4–7)
|
3 (2–7)
|
0.246
|
|
PICU mortality
|
32 (53.3%)
|
2 (8%)
|
30 (85.7%)
|
< 0.0001
|
